independence Indian Pharma profession has grown
tremendously and has become selfsufficient industry
known for producing Quality Medicine at economic price
worldwide. There are 26,000 pharmaceutical companies in
India and out of them 300 are organized sector. Domestic
sale of Medicine is Rs. 42,000 crores and will reach to
Rs.1,00,000 crores around 2012. First 50 companies
produce 75% of total sales.
Export of Drugs and Medicine is around Rs. 15000 crores
and around 2012 it will go to 50,000 crores. 70% of
Export is bulk drug (active ingredients) and companies
like orchid (Chennai based) and Dr. Reddy’s Laboratories
(Hyderabad based) are the leading giants in this
category. There are 85 therapeutic segments and 80,000
brands (Ex. Crocin is a brand which contains Paracetamol).
Therapeutic segment means drugs useful in specific
category for ex. Diabetes, Cancer etc. Due to product
patent acceptance and implementation from Jan 2005 many
Indian pharmaceutical companies like Ranbaxy, Dr. Reddys
Laboratories, Lupin Ltd, Sun Pharma, Glenmark, Wockhardt,
Zydus Cadila, Torrent, started investment in tune of 10%
of sales in Research and Development. R and D investment
will reach to Rs.40,000 crores around 2012.
Today 40 % of the world’s bulk drugs requirement is met
by India. 15% Scientists working in drug discovery
laboratories in USA are Indians. Clinical Research
Industry will be around Rs. 40,000 crores around 2012,
opening many job opportunities. India is emerging as a
global source of vaccines (SERUM, BIOCON, SHANTA,
BHARAT). Biotech product market will be around Rs.
23,000 crores in 2010. Herbal Drugs Market around 2012
will be around Rs. 6,000 crores. Companies like Dabur,
Zandu, Himalaya, Sami Chemicals are leading exporters.
Global players are looking at India for tremendous
outsourcing opportunities and various other activities.
For full text of this article contact the publisher on